Research Scientist - RTKs
Jazz Pharmaceuticals
Summary
Responsible for designing and executing experiments relating to the discovery and nonclinical evaluation of efficacy and mechanism of action of anticancer therapies with little supervision, with a specific focus on receptor tyrosine kinases (e.g. HER2, EGFR). Responsible for documenting and archiving experimental protocols, data, analyses, and conclusions according to established laboratory procedures. Expected to participate in communication of research into publications, conference presentations, abstracts, and patent applications. Self-motivated and works under general supervision on multiple projects. This position is a full time laboratory-based position.
Job description
Essential Functions/Responsibilities
- Manage cell culture of cancer and normal cell lines.
- Perform in vitro pharmacology assays associated with the discovery and characterization of RTK-targeted therapies.
- Perform in vitro efficacy, mechanism of action, target validation, and biomarker studies with cancer therapeutics, with an emphasis on RTK-driven disease models.
- Present summary results for internal communications and external presentations.
- Support preparation of conference abstracts and manuscripts for publication as needed.
- Develop proper operational, data documentation, and troubleshooting procedures.
- Such other responsibilities and projects that the Company may assign.
Required Knowledge, Skills, and Abilities
- Requires the ability to perform routine laboratory work, sit or stand at a computer for long stretches of time and type. Frequently operates a computer and other office productivity machinery, such as a calculator, copy machine, and computer printer. The person in this position needs to occasionally move about inside the office to access file cabinets and office equipment. May occasionally lift objects up to 25 pounds.
- Three or more years of industry or post-doctoral experience in oncology.
- Demonstrated expertise in receptor tyrosine kinase biology, preferably including HER2 or EGFR, with experience characterizing RTK signaling, pathway modulation, and therapeutic mechanisms of action.
- Experience in oncology and pharmacology assays and techniques.
- Experience with small molecule and biologic-based therapies.
- Exceptional written and verbal communication including publications and conference presentations.
- Team player who is highly organized and able to manage multiple concurrent projects with minimal oversight.
- Forward-thinking with the ability to anticipate challenges and proactively implement solutions.
- Computer proficient.
- Experience driving advancement of numerous projects simultaneously.
- Ability to identify and initiate tasks, set goals for completion, create timelines, and monitor progress to ensure completion.
- Strong sense of urgency to meet business needs.
- A positive, "hands-on" approach to the position.
- Demonstrated ability to react and respond professionally to changing priorities and timelines.
- Demonstrated success in working in a matrix, cross-functional environment.
- Demonstrated ability to communicate clearly both written and oral and work independently with a high level of attention to detail.
Required/Preferred Education and Licenses
- Ph.D. in cancer biology, molecular/cell biology, biochemistry, pharmacology, or related fields, or master's degree with relevant experience.
Requirements
- Three or more years of industry or post-doctoral experience in oncology
- Demonstrated expertise in receptor tyrosine kinase biology, preferably including HER2 or EGFR
- Experience characterizing RTK signaling, pathway modulation, and therapeutic mechanisms of action
- Experience in oncology and pharmacology assays and techniques
- Experience with small molecule and biologic-based therapies
- Exceptional written and verbal communication including publications and conference presentations
- Highly organized and able to manage multiple concurrent projects with minimal oversight
- Forward-thinking with ability to anticipate challenges and proactively implement solutions
- Computer proficient
- Experience driving advancement of numerous projects simultaneously
- Ability to identify and initiate tasks, set goals, create timelines, and monitor progress
- Strong sense of urgency to meet business needs
- Positive, hands-on approach
- Ability to react and respond professionally to changing priorities and timelines
- Demonstrated success in a matrix, cross-functional environment
- Ability to communicate clearly both written and oral and work independently with high attention to detail
- Ph.D. in cancer biology, molecular/cell biology, biochemistry, pharmacology, or related fields, or master's degree with relevant experience
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Flexible Paid Vacation
- Discretionary Annual Cash Bonus
- Discretionary Equity Grants
Company overview
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, with significant operations in the United States and Europe. Founded in 2003 in California, the company specializes in developing and commercializing innovative medicines for patients with serious diseases, with a primary focus on oncology and neuroscience. Jazz Pharmaceuticals is renowned for its flagship product Xyrem (sodium oxybate), which treats excessive daytime sleepiness and cataplexy in narcolepsy patients, generating substantial revenue for the company. The company's portfolio also includes treatments for epilepsy, sleep disorders, hematology, and oncology, with notable products such as Erwinaze, Defitelio, FazaClo, and Vyxeos. Through strategic acquisitions including GW Pharmaceuticals in 2021, Jazz expanded its neuroscience portfolio with cannabis-based medicines like Epidiolex for severe epilepsy syndromes. With approximately 2,800 employees worldwide and operations across multiple continents, Jazz Pharmaceuticals maintains a strong commitment to research and development, focusing on transforming biopharmaceutical discoveries into novel therapies for patients with limited treatment options. The company operates manufacturing facilities in Ireland, England, and Italy, and continues to pursue innovative approaches to address critical unmet medical needs in specialized therapeutic areas.